Literature DB >> 27093761

Diabetes Mellitus Review.

Meg Blair.   

Abstract

Diabetes mellitus is a group of physiological dysfunctions characterized by hyperglycemia resulting directly from insulin resistance, inadequate insulin secretion, or excessive glucagon secretion. Type 1 diabetes (T1D) is an autoimmune disorder leading to the destruction of pancreatic beta-cells. Type 2 diabetes (T2D), which is much more common, is primarily a problem of progressively impaired glucose regulation due to a combination of dysfunctional pancreatic beta cells and insulin resistance. The purpose of this article is to review the basic science of type 2 diabetes and its complications, and to discuss the most recent treatment guidelines.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27093761

Source DB:  PubMed          Journal:  Urol Nurs        ISSN: 1053-816X


  36 in total

1.  Catalpol ameliorates diabetic atherosclerosis in diabetic rabbits.

Authors:  Jiang-Yue Liu; Chen-Zhao Zheng; Xin-Ping Hao; Dai-Juan Zhang; An-Wei Mao; Ping Yuan
Journal:  Am J Transl Res       Date:  2016-10-15       Impact factor: 4.060

Review 2.  Mesenchymal Stem/Progenitor Cells: The Prospect of Human Clinical Translation.

Authors:  Dina Rady; Marwa M S Abbass; Aiah A El-Rashidy; Sara El Moshy; Israa Ahmed Radwan; Christof E Dörfer; Karim M Fawzy El-Sayed
Journal:  Stem Cells Int       Date:  2020-08-11       Impact factor: 5.443

3.  In Vivo Imaging of Ischemia/Reperfusion-mediated Aminopeptidase N Expression in Surgical Rat Model Using 68Ga-NOTA-c(NGR).

Authors:  János Hunyadi; György Trencsényi; Gergely Farkasinszky; Noémi Dénes; Szilvia Rácz; Adrienn Kis; Judit Szabó Péliné; Gábor Opposits; Gergő Veres; László Balkay; István Kertész; Gábor Mező
Journal:  In Vivo       Date:  2022 Mar-Apr       Impact factor: 2.155

Review 4.  Role of Inflammatory Cytokines, Growth Factors and Adipokines in Adipogenesis and Insulin Resistance.

Authors:  Layla Al-Mansoori; Hend Al-Jaber; Mohammad Shoaib Prince; Mohamed A Elrayess
Journal:  Inflammation       Date:  2021-09-18       Impact factor: 4.092

5.  Impact of SARS-CoV-2 Pandemic on Glycaemic Control, Metabolic Status, Treatment Adherence, Quality of Life in Diabetes Mellitus Patients in Tertiary Care Hospital of Eastern India.

Authors:  Nidhi Kumari; Ved Prakash; Sukalyan Saha Roy; Manish Kumar; Hitesh Mishra; Harihar Dikshit
Journal:  Maedica (Bucur)       Date:  2022-03

Review 6.  COVID-19 and diabetes: What do we know so far?

Authors:  Prakash Gangadaran; Himabindu Padinjarathil; Shri Hari Subhashri Rajendran; Manasi P Jogalekar; Chae Moon Hong; Baladhandapani Aruchamy; Uma Maheswari Rajendran; Sridharan Gurunagarajan; Anand Krishnan; Prasanna Ramani; Kavimani Subramanian
Journal:  Exp Biol Med (Maywood)       Date:  2022-07-27

7.  Scavenging of reactive oxygen and nitrogen species with nanomaterials.

Authors:  Carolina A Ferreira; Dalong Ni; Zachary T Rosenkrans; Weibo Cai
Journal:  Nano Res       Date:  2018-05-26       Impact factor: 8.897

Review 8.  Review of Pharmacokinetic Data of Different Drug Classes in Goto-Kakizaki Rats, a Non-obese Model for Type 2 Diabetes Mellitus: Case Studies and Perspectives.

Authors:  Harilal Patel; Poonam Giri; Nuggehally R Srinivas
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-04       Impact factor: 2.441

9.  The Effect of Vitamin D Supplementation on Serum and Muscle Irisin Levels, and FNDC5 Expression in Diabetic Rats.

Authors:  Hoda Nadimi; Abolghassem Djazayery; Mohammad Hassan Javanbakht; Ahmadreza Dehpour; Ehsan Ghaedi; Hoda Derakhshanian; Hamed Mohammadi; Mahnaz Zarei; Mahmoud Djalali
Journal:  Rep Biochem Mol Biol       Date:  2019-10

Review 10.  Heliotropium indicum L.: From Farm to a Source of Bioactive Compounds with Therapeutic Activity.

Authors:  Chandan Sarkar; Milon Mondal; Bilkis Khanom; Md Monir Hossain; Md Solayman Hossain; Antoni Sureda; Muhammad Torequl Islam; Miquel Martorell; Manoj Kumar; Javad Sharifi-Rad; Ahmed Al-Harrasi; Ahmed Al-Rawahi
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-01       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.